Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.

Lobo M, Balouz V, Melli L, Carlevaro G, Cortina ME, Cámara MLM, Cánepa GE, Carmona SJ, Altcheh J, Campetella O, Ciocchini AE, Agüero F, Mucci J, Buscaglia CA.

PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007245. doi: 10.1371/journal.pntd.0007245. [Epub ahead of print]

2.

Isolation and Phenotypic Characterization of Inflammatory Cells from Clinical Samples: Purification of Macrophages from Trypanosoma cruzi-Infected Hearts.

Eberhardt N, Sanmarco LM, Aoki MP.

Methods Mol Biol. 2019;1955:381-395. doi: 10.1007/978-1-4939-9148-8_28.

PMID:
30868542
3.

Fluorescence Proteomic Technology to Analyze Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.

Wiktorowicz JE, Zago MP, Garg NJ.

Methods Mol Biol. 2019;1955:363-380. doi: 10.1007/978-1-4939-9148-8_27.

PMID:
30868541
4.

CD8+ T Cell Response to Trypanosoma cruzi Antigens during Chronic Chagas Disease.

Lasso P, Mateus J, González JM, Cuéllar A, Puerta C.

Methods Mol Biol. 2019;1955:349-361. doi: 10.1007/978-1-4939-9148-8_26.

PMID:
30868540
5.

Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.

Albareda MC, Natale MA, Cesar GL, Castro Eiro MD, Alvarez MG, Laucella SA.

Methods Mol Biol. 2019;1955:339-348. doi: 10.1007/978-1-4939-9148-8_25.

PMID:
30868539
6.

Generation of T. cruzi-Specific Primary CD4+ T Cell Lines from Peripheral Blood Mononuclear Cells Isolated from Chagas Disease Patients.

Acevedo GR, Alcaráz PB, Pinilla C, Gómez KA.

Methods Mol Biol. 2019;1955:315-337. doi: 10.1007/978-1-4939-9148-8_24.

PMID:
30868538
7.

Cytometric Bead Array (CBA) for Measuring Cytokine Levels in Chagas Disease Patients.

Medeiros NI, Gomes JAS.

Methods Mol Biol. 2019;1955:309-314. doi: 10.1007/978-1-4939-9148-8_23.

PMID:
30868537
8.

Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.

Ortega-Rodriguez U, Portillo S, Ashmus RA, Duran JA, Schocker NS, Iniguez E, Montoya AL, Zepeda BG, Olivas JJ, Karimi NH, Alonso-Padilla J, Izquierdo L, Pinazo MJ, de Noya BA, Noya O, Maldonado RA, Torrico F, Gascon J, Michael K, Almeida IC.

Methods Mol Biol. 2019;1955:287-308. doi: 10.1007/978-1-4939-9148-8_22.

PMID:
30868536
9.

Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers in Plasma.

Alonso-Padilla J, Tassies D, Cortes-Serra N, Gascon J, Reverter JC, Pinazo MJ.

Methods Mol Biol. 2019;1955:275-286. doi: 10.1007/978-1-4939-9148-8_21.

PMID:
30868535
10.

Apolipoprotein A1 and Fibronectin Fragments as Markers of Cure for the Chagas Disease.

Ruiz-Lancheros E, Golizeh M, Ndao M.

Methods Mol Biol. 2019;1955:263-273. doi: 10.1007/978-1-4939-9148-8_20.

PMID:
30868534
11.

Analytics of Functional Autoantibodies in Patients with Chagas Disease.

Wallukat G, Wenzel K, Schimke I.

Methods Mol Biol. 2019;1955:247-261. doi: 10.1007/978-1-4939-9148-8_19.

PMID:
30868533
12.

Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase.

Leguizamón MS.

Methods Mol Biol. 2019;1955:239-246. doi: 10.1007/978-1-4939-9148-8_18.

PMID:
30868532
13.

Genotyping of Trypanosoma cruzi from Clinical Samples by Multilocus Conventional PCR.

da Cruz Moreira O, Ramirez JC.

Methods Mol Biol. 2019;1955:227-238. doi: 10.1007/978-1-4939-9148-8_17.

PMID:
30868531
14.

Assessing Parasite Load in Chagas Disease Patients by Quantitative Multiplex Real-Time PCR.

Ramírez JC, da Cruz Moreira O.

Methods Mol Biol. 2019;1955:215-225. doi: 10.1007/978-1-4939-9148-8_16.

PMID:
30868530
15.

Multi-Parametric Evaluation of Trypanosoma cruzi Infection Outcome in Animal Models.

Santi-Rocca J, Gironès N, Fresno M.

Methods Mol Biol. 2019;1955:187-202. doi: 10.1007/978-1-4939-9148-8_14.

PMID:
30868528
16.

In Situ Detection of Dormant Trypanosoma cruzi Amastigotes Using Bioluminescent-Fluorescent Reporters.

Sánchez-Valdéz F, Padilla A.

Methods Mol Biol. 2019;1955:179-186. doi: 10.1007/978-1-4939-9148-8_13.

PMID:
30868527
17.

Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions.

Taylor MC, Francisco AF, Jayawardhana S, Mann GS, Ward AI, Olmo F, Lewis MD, Kelly JM.

Methods Mol Biol. 2019;1955:147-163. doi: 10.1007/978-1-4939-9148-8_11.

PMID:
30868525
18.

Metabolic Labeling of Surface Neo-sialylglyconjugates Catalyzed by Trypanosoma cruzi trans-Sialidase.

Carlevaro G, Lantos AB, Cánepa GE, de Los Milagros Cámara M, Somoza M, Buscaglia CA, Campetella O, Mucci J.

Methods Mol Biol. 2019;1955:135-146. doi: 10.1007/978-1-4939-9148-8_10.

PMID:
30868524
19.

Production of Recombinant Trypanosoma cruzi Antigens in Leishmania tarentolae.

Ferrer MJ, Wehrendt DP, Bonilla M, Comini MA, Tellez-Iñón MT, Potenza M.

Methods Mol Biol. 2019;1955:105-118. doi: 10.1007/978-1-4939-9148-8_8.

PMID:
30868522
20.

Isolation and Characterization of Extracellular Vesicles Derived from Trypanosoma cruzi.

Rossi IV, Gavinho B, Ramirez MI.

Methods Mol Biol. 2019;1955:89-104. doi: 10.1007/978-1-4939-9148-8_7.

PMID:
30868521

Supplemental Content

Loading ...
Support Center